Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...

Preparing for the Actors Circle production of ‘A Midsummer Night’s Dream’ are, from left: Julia Moran, Paul Miscavage, Chris Norton, K.K. Gordon, Skylar Conway, Kilber Rubio, Jason Belak, Danielle ...

Circle’s USD Coin is gaining momentum as a digital alternative to real U.S. dollars. It has plenty of room to grow, but it probably isn’t a millionaire-maker stock. Circle's USD Coin, a cryptocurrency ...

Image source: Getty Images. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical ...

How does Circle make money? Circle's USD Coin, a cryptocurrency pegged to the U.S. dollar, is used to settle cross-border transactions at faster and cheaper rates than conventional interbank transfers ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 million in an initial public offering, as listing activity in ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

Generate:Biomedicines is hoping to raise up to $425 million via a Nasdaq IPO, with the proceeds needed to bankroll its lead antibody through respiratory disease trials. The Flagship Pioneering-founded ...

COLORADO SPRINGS, Colo. (KRDO) - For the volunteers with Richards Rubbish Roundup, their cleanup on Tuesday afternoon is anything but random. "Some of them, their favorite thing to do, is see how many ...